References
- Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. World Health Organization. Geneva: World Health Organization, 2021; 108 p. ISBN 978-92-4-002708-4 (print version) ISBN 978-92-4-002707-7 (electronic version). Available from:
https://www.who.int/publications/i/item/9789240027077 - Global health sector strategy on viral hepatitis 2016–2021: Towards ending viral hepatitis. World Health Organization. Geneva: World Health Organization, 2016; 53 p. WHO reference number: WHO/HIV/2016.06. Available from:
https://www.who.int/publications/i/item/WHO-HIV-2016.06 - Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016–2021. World Health Organization. Geneva : World Health Organization, 2019; 39 p. WHO Document number: WHO/CDS/HIV/19.7. Available from:
https://apps.who.int/iris/handle/10665/324797 - Combating hepatitis B and C to reach elimination by 2030: advocacy brief. World Health Organization. Geneva: World Health Organization, 2016; 17 p. WHO document number: WHO/HIV/2016.04. Available from:
https://apps.who.int/iris/handle/10665/206453 - Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17(9):533–42. doi: 10.1038/s41575-020-0332-6
- Thomas DL. Global Elimination of Chronic Hepatitis. N Engl J Med. 2019;380(21):2041–50. doi: 10.1056/NEJMra1810477
- Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12(3):258–63. doi: 10.1038/cmi.2014.79
- Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci. 2021;22(11):5497. doi: 10.3390/ijms22115497
- Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. doi: 10.1002/hep.29800
- Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, et al.; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019;4(7):545–558. doi: 10.1016/S2468-1253(19)30119-0. Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7. doi: doi: 10.1016/S2468-1253(19)30151-7
- Bhat SA, Kazim SN. HBV cccDNA-A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure. ACS Omega. 2022;7(28):24066–81. doi: 10.1021/acsomega.2c02216
- Revill PA, Penicaud C, Brechot C, Zoulim F. Meeting the challenge of eliminating chronic hepatitis B infection. Genes (Basel). 2019;10(4):260. doi: 10.3390/genes10040260
- Lucifora J, Protzer U. Attacking hepatitis B virus cccDNA—the holy grail to hepatitis B cure. J Hepatol. 2016;64(1 Suppl):S41–S48. doi: 10.1016/j.jhep.2016.02.009
- Indolfi G, Abdel-Hady M, Bansal S, Debray D, Smets F, Czubkowski P, et al. Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies. J Pediatr Gastroenterol Nutr. 2020;70(4):527–538. doi: 10.1097/MPG.0000000000002628
- Hepatitis B. pp. 401-28. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2018–2021 Report of the Committee on Infectious Diseases. Committee on Infectious Diseases, American Academy of Pediatrics. 31st Edition. Itasca, IL: American Academy of Pediatrics, 2018:401–28. ISBN 978-1-61002-146-3. doi: 10.1542/9781610021470 (book doi). doi: 10.1542/9781610021470-part03-hepatitis_b (chapter doi)
- El Agheb MO, Grange JD. Prévention de la transmission mèreenfant de l’hépatite B. (Prevention of mother to child transmission of hepatitis B). Pan Afr Med J. 2015;20:316. French. doi: 10.11604/pamj.2015.20.316.6193
- European Association for the Study of the Liver; Collaborators: Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370–398. doi: 10.1016/j.jhep.2017.03.021
- Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404. doi: 10.3748/wjg.v20.i30.10395
- Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43(3):556–62. doi: 10.1002/hep.21077
- Lu FT, Ni YH. Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience. Pediatr Gastroenterol Hepatol Nutr. 2020;23(4):311–8. doi: 10.5223/pghn.2020.23.4.311
- Komatsu H, Inui A, Fujisawa T. Pediatric hepatitis B treatment. Ann Transl Med. 2017;5(3):37. doi: 10.21037/atm.2016.11.52
- Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol. 2021;27(36):6053–63. doi: 10.3748/wjg.v27.i36.6053
- Mysore KR, Leung DH. Hepatitis B and C. Clin Liver Dis. 2018;22(4):703–22. doi: 10.1016/j.cld.2018.06.002
- WHO guidelines on hepatitis B and C testing. World Health Organization. Geneva: World Health Organization, 2017; 170 p. ISBN 978-92-4-154998-1. Available from:
https://www.who.int/publications/i/item/9789241549981 - Costa JM, Telehin D, Munteanu M, Kobryn T, Ngo Y, Thibault V, et al. HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol. 2011;35(3):204–13. doi: 10.1016/j.clinre.2011.01.005
- Mărginean CO, Meliț LE, Săsăran MO. Elastography—a bona fide non-invasive method for assessing non-alcoholic fatty liver disease in children. Applied Sciences. 2021;11(7):3240. doi: 10.3390/app11073240
- Rodriguez-Baez N, Murray KF, Kleiner DE, Ling SC, Rosenthal P, Carlin K, et al. Hepatic histology in treatment-naïve children with chronic hepatitis B infection living in the United States and Canada. J Pediatr Gastroenterol Nutr. 2020;71(1): 99–105. doi: 10.1097/MPG.0000000000002712
- Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):466–76. doi: 10.1016/S2468-1253(19)30042-1. Erratum in: Lancet Gastroenterol Hepatol. 2020;5(5):e4. doi: 10.1016/S2468-1253(20)30092-3
- Wong WWL, Pechivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, et al. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2019;8(1):207. doi: 10.1186/s13643-019-1126-1
- Wei S, Hu M, Chen H, Xie Q, Wang P, Li H, et al. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study. BMC Gastroenterol. 2022;22(1):387. doi: 10.1186/s12876-022-02471-y
- Li M, Sun F, Bi X, Lin Y, Yang L, Lu Y, et al. Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virol Sin. 2022;37(3):390–7. doi: 10.1016/j.virs.2022.03.001
- Pan J, Wang H, Yao T, Liao X, Cheng H, Liangpunsakul S, et al. Clinical predictors of functional cure in children 1–6 years-old with chronic hepatitis B. J Clin Transl Hepatol. 2022;10(3):405–11. doi: 10.14218/JCTH.2021.00142
- Zhong YW, Shi YM, Chu F, Liu J, Shi C, Xu JJ, et al. Prediction for HBsAg seroconversion in children with chronic hepatitis B. BMC Infect Dis. 2021;21(1):1211. doi: 10.1186/s12879-021-06883-1
- Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98. doi: 10.1007/s12072-015-9675-4.
- Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. World Health Organization; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. Geneva, Switzerland : WHO, March 2015; XXX, 134 p. ISBN 978 92 4 154905 9. Available from:
https://www.who.int/publications/i/item/9789241549059 - NICE National Institute for Health and Care Excellence. Hepatitis B (chronic): diagnosis and management : clinical guideline. CG165. London, Manchester, UK: NICE, published June 2013, corrected January 2014, last updated October 2017; 36 p. Published 26 June 2013. Las Updated 20 October 2017. ISBN 978-1-4731-4724-9. Available from:
https://www.nice.org.uk/guidance/cg165 - Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, Kelly D, Mieli-Vergani G; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol. 2013 Oct;59(4):814–29. doi: 10.1016/j.jhep.2013.05.016